TrialClinical genitourinary cancer2017

A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma.

Andrea B Apolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.